In addition, HN silencing impaired GBM cell migratory and proangiogenic properties, suggesting that the local administration of these vectors could constitute an interesting strategy to aid in the treatment of this aggressive tumor. The gene discussed is MT-RNR2; the disease is glioblastoma.